{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:09:45Z","timestamp":1793189385984,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Pterygium is a common ocular surface disease defined by fibrovascular conjunctival growth extending onto the cornea. However, its pathogenesis remains unclear. This study aimed to determine the role of CD44, proliferating cell nuclear antigen (PCNA), and E-cadherin in pterygium formation and recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Sixty patients with pterygium participated in the study, and we collected conjunctival samples from 30 patients to form a control group. CD44, PCNA, and E-cadherin expressions in surgically excised pterygium were compared with tissue samples from the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We observed that the percentages of CD44 and PCNA were statistically higher in the primary pterygium group and recurrent pterygium group than in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001, respectively). Conversely, E-cadherin values were statistically higher in the control group than in the primary and recurrent pterygium groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cell proliferation and cell adhesion factors may play important roles in the pathogenesis of pterygium.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2579_23","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T04:00:52Z","timestamp":1713585652000},"page":"S501-S504","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Expression of CD44, PCNA and E-cadherin in pterygium tissues"],"prefix":"10.4103","volume":"72","author":[{"given":"Humeyra","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Bal\u0131kesir University, Faculty of Medicine, Bal\u0131kesir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulay","family":"Turan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bal\u0131kesir University, Faculty of Medicine, Bal\u0131kesir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meydan","family":"Turan","sequence":"additional","affiliation":[{"name":"Balikesir Ataturk C\u0131ty Hospital, Ophthalmology, Balikesir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"R1-20260504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00003226-199801000-00005","article-title":"Correlation between pterygium size and induced corneal astigmatism","volume":"17","author":"Lin","year":"1998","journal-title":"Cornea"},{"key":"R2-20260504","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/02713683.2013.823212","article-title":"Progress in the pathogenesis of pterygium","volume":"38","author":"Liu","year":"2013","journal-title":"Curr Eye Res"},{"key":"R3-20260504","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.3390\/ijerph191811357","article-title":"Evaluating the efficacy and safety of different pterygium surgeries: A review of the literature","volume":"19","author":"Palewski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R4-20260504","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/08820538.2014.971822","article-title":"Molecular basis of pterygium development","volume":"31","author":"C\u00e1rdenas-Cant\u00fa","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"R5-20260504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","article-title":"Pathogenesis of pterygia: Role of cytokines, growth factors, and matrix metalloproteinases","volume":"23","author":"Di Girolamo","year":"2004","journal-title":"Progr Retin Eye Res"},{"key":"R6-20260504","first-page":"563","article-title":"The role of heredity in pterygium development","volume":"7","author":"Anguria","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"R7-20260504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/ICO.0000000000002575","article-title":"Systematic review: The effects of pterygium and pingueculum on the ocular surface and the efficacy of surgical excision","volume":"40","author":"Linaburg","year":"2021","journal-title":"Cornea"},{"key":"R8-20260504","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2147\/OPTH.S186543","article-title":"How to minimize pterygium recurrence rates: Clinical perspectives","volume":"12","author":"Nuzzi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R9-20260504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archophthalmol.2012.2599","article-title":"Limbal-conjunctival vs conjunctival autograft transplant for recurrent pterygia: A prospective randomized controlled trial","volume":"131","author":"Al Fayez","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R11-20260504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"51","author":"Goodison","year":"1999","journal-title":"Mol Pathol"},{"key":"R12-20260504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.onc.1200886","article-title":"PCNA: Structure, functions and interactions","volume":"14","author":"Kelman","year":"1997","journal-title":"Oncogene"},{"key":"R13-20260504","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.breast.2008.02.002","article-title":"Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients","volume":"17","author":"Stuart-Harris","year":"2008","journal-title":"Breast"},{"key":"R14-20260504","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/302173","article-title":"The tumor-suppressor function of E-cadherin","volume":"63","author":"Semb","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R15-20260504","doi-asserted-by":"crossref","first-page":"16445","DOI":"10.18632\/oncotarget.14860","article-title":"Prognostic value of reduced E-cadherin expression in breast cancer: A meta-analysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"R16-20260504","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in cancer\u2014A review","volume":"21","author":"Kaszak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R17-20260504","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archopht.1997.01100160405001","article-title":"Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision","volume":"115","author":"Tan","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R18-20260504","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","article-title":"The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: Signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"key":"R19-20260504","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1167\/iovs.06-1060","article-title":"\u03b2-Catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium","volume":"48","author":"Kato","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20260504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R21-20260504","first-page":"3929","article-title":"Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer","volume":"54","author":"Umbas","year":"1994","journal-title":"Cancer Res"},{"key":"R22-20260504","first-page":"4789","article-title":"Expression of E-cadherin and \u03b2-catenin in human non-small cell lung cancer and the clinical significance","volume":"6","author":"Kase","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R23-20260504","doi-asserted-by":"crossref","first-page":"e70858","DOI":"10.1371\/journal.pone.0070858","article-title":"Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: Evidence from meta-analysis","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"R24-20260504","first-page":"1038069","article-title":"GTSE1, CDC20, PCNA, and MCM6 synergistically affect regulations in cell cycle and indicate poor prognosis in liver cancer","volume":"2019","author":"Zheng","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"key":"R25-20260504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12903-019-0928-9","article-title":"Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma","volume":"19","author":"Lu","year":"2019","journal-title":"BMC Oral Health"},{"key":"R26-20260504","first-page":"3049","article-title":"Correlation between proliferation markers: PCNA, Ki-67, MCM\u20132 and antiapoptotic protein Bcl-2 in colorectal cancer","volume":"29","author":"Guzi\u0144ska-Ustymowicz","year":"2009","journal-title":"Anticancer Res"},{"key":"R27-20260504","first-page":"1687","article-title":"Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva","volume":"17","author":"Liang","year":"2011","journal-title":"Mol Vis"},{"key":"R28-20260504","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bjo.2006.110387","article-title":"Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium","volume":"91","author":"Kase","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R29-20260504","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/1120672120945903","article-title":"Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence","volume":"30","author":"Turan","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"R30-20260504","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jcp.24145","article-title":"Co-expression of CD133+\/CD44+in human colon cancer and liver metastasis","volume":"228","author":"Bellizzi","year":"2013","journal-title":"J Cell Physiol"},{"key":"R31-20260504","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/ijc.24868","article-title":"Cancer stem\/progenitor cells are highly enriched in CD133+CD44+population in hepatocellular carcinoma","volume":"126","author":"Zhu","year":"2010","journal-title":"Int J Cancer"},{"key":"R32-20260504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopha.2014.08.001","article-title":"The prognostic value of CD44 expression in gastric cancer: A meta-analysis","volume":"68","author":"Chen","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"R33-20260504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fonc.2019.00309","article-title":"The prognostic and clinical value of CD44 in colorectal cancer: A meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2579_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:33:36Z","timestamp":1787769216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2579_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":32,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2579_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"2023-09-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}